AzTrials
AzTrials

Healthy Adult ParticipantsEBA-QNCT07536685

THE TURKISH VERSION OF THE EKSTEROCEPTIVE BODY AWARENESS QUESTIONNAIRE

An observational study of Healthy Adult Participants, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

Our study was planned to establish the validity and reliability of the EBA-Q Questionnaire, developed to determine external body awareness, in Turkish and to contribute it to the literature for use in research. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy Adult Participants
What is being tested?
Survey using a questionnaire.
How many people
180 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Apr 2026to 20 Aug 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy individuals

Who may be able to join

  • Those who can read and write Turkish
  • have any brain damage, serious musculoskeletal problems, or neurological problems.

Who cannot join

  • Individuals with cognitive, mental, or psychological problems
  • have received body awareness/perception training excluded from the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Kütahya Health Sciences University

    Kütahya, Kütahya, 43020

Other trials in Turkey (Türkiye)

About this study

Official title: VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF THE EKSTEROCEPTIVE BODY AWARENESS QUESTIONNAIRE

Our study was planned to establish the validity and reliability of the EBA-Q Questionnaire, developed to determine external body awareness, in Turkish and to contribute it to the literature for use in research.

Read the detailed description

Examining body awareness in all its aspects is a fundamental concept for a deeper understanding of mind-body interactions, and body awareness assessments and treatments have been frequently used in the field of physiotherapy and rehabilitation in recent years. The current body awareness self-report measures are only items related to internal perception or body perception questionnaires that measure internal perception and proprioception, but the only questionnaire we encountered in the literature that assesses exteroceptive awareness is the exteroceptive body awareness questionnaire (EBA-Q) developed in 2023. EBA-Q is an assessment tool used to measure a person's ability to perceive their own body based on exteroceptive signals and to accurately evaluate changes.

Being tested
Survey using a questionnaire.
Keywords
exteroceptive, body awareness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Survey using a questionnaire.Other

    survey measurement

Study groups in NCT07536685
Study groupRoleWhat they receive
single grouphealthy individuals
Receives: Other: Survey using a questionnaire.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EBA-Q

    The EBA-Q is an assessment tool used to measure a person's ability to perceive their own body based on exteroceptive signals and accurately evaluate changes. The 18-item questionnaire consists of four subscales: visual-tactile body awareness (7 items measuring the sensitivity to assessing whether the body can pass through narrow passages or under low ceilings, and the sensitivity to detecting other people's touch, insects, sweat, and puddles); spatial coordination (4 items measuring the level of spatial awareness when interacting with objects in space, such as bumping into people and furniture); awareness of body changes (4 items asking about weight changes, the appearance of scars and moles, and tanning); and awareness of clothing fit (3 items measuring the relationship between clothing, belts, shoes, and body size). It is evaluated using a 5-point Likert scale (1=not at all appropriate, 5=very appropriate).High scores indicate high awareness.

    Measured: DAY 1

  2. SAS

    The Turkish validity and reliability study of the two subscales (SSI, SSI) that we will use in our study, which consist of 3 subcategories (private self-awareness=SSA, social self-awareness=SSA, and social anxiety) and a total of 22 questions, was conducted by Neslihan Rugancı in 1995 (13). SSI, consisting of 9 items, is an internal self-awareness structure and includes items related to individuals having a positive awareness of their emotional states that is free from subjectivity, and items related to self-reflection, items related to the individual's thinking, imagining, and evaluating themselves regarding their past, experiences, value judgments, and behaviors. SSI, consisting of 7 items, includes items related to the individual's tendencies regarding their behavior patterns and their interest in a certain image they want to present to society. The scale items are evaluated with a 4-point Likert scale (1=Disagree, 4=Strongly Agree). High scores obtained high awareness

    Measured: DAY 1

Secondary outcomes (1)
  1. MAIA-2

    The questionnaire developed in 2018, used to measure eight dimensions of internal body awareness, consists of a total of 37 items. It is evaluated using a six-level Likert scale from 0 (never) to 5 (always) (6). It consists of the following sub-parameters: Awareness (4 items), Distraction-Free (6 items), Non-Worry (5 items, α=0.67), Attention Regulation (7 items), Emotional Awareness (5 items), Self-Regulation (4 items), Body Listening (3 items), and Trust (3 items). The Cronbach's alpha value of the sub-parameters ranges from 0.64 to 0.83. The Turkish validity and reliability were established by Özpınar. For the Turkish translation of EBAQ, the Awareness and Body Listening, Attention Regulation, and Non-Worry subscales (total 18 items) used in the original questionnaire will be utilized. High scores indicate high awareness.

    Measured: DAY 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2026
  2. Study start10 Apr 2026
  3. Primary completion20 Jun 2026 (estimated)
  4. Study completion20 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07536685
Sponsor's protocol ID
KHSU-ST-04
Acronym
EBA-Q
Status last verified
Apr 2026
First submitted
6 Apr 2026
Last updated
17 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The study is conducted on healthy volunteers and is planned to be shared with authorities upon request.

Publications

  • Vabba A, Porciello G, Panasiti MS, Aglioti SM. Development and validation of the Exteroceptive Body Awareness (EBA-q) questionnaire. PeerJ. 2023 Aug 24;11:e15382. doi: 10.7717/peerj.15382. eCollection 2023.

    PubMed 37641601

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy Adult Participants, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 17 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EBA-Q (time frame: DAY 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07536685, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in